Clinical Trial Update: Omega 3 Supplementation in Fatty Liver [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acid supplementation for fatty liver has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease

Drugs mentioned

• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Fatty Liver | Phase 3 | Status: COMPLETED